Registration & Morning Coffee


Chairperson Opening Remarks

Shingo Arioka
Research Manager
Shionogi & Japan Microbiome Consortium


Host-Microbiome Interactions that Cause Disease

Session Purpose:

As the gut microbiome continues to be at the forefront of medical research, both the industrial and academic communities expect
that insights gained from microorganisms will soon become a critical component of health management across a gamut of critical
indications. However, the biggest hurdle in translating promising gut microbiome research into effective therapeutic candidates is
demonstrating the causative role of human microbiome in disease pathology. Although there are a growing number of microbiomebased candidates showing promising results in both pre-clinical and clinical settings, the approaches that are likely to have
well-validated mechanisms of action are limited. The purpose of this theme will be to review the current thinking in approaching the
human microbiome mechanistically and understanding both the academic and industrial perspectives on this important topic.


Microbiome, Host Genetics, and Metabolic Diseases



GwangPyo Ko
Founder and CEO



Impact of the Gut Microbiota in Korean Patients with GI Diseases

Changsoo Eun
Professor, Internal Medicine
Hanyang University College
of Medicine


Speed Networking Session


Morning Coffee & Refreshments Break


Faecalibacterium Prausnitzii Dynamics in the Human Gut Microbiome Underlying Atopic Dermatitis

Heenam Stanley Kim
Korea University, College of Health Sciences

Establishing Standardised Protocols for Microbiome Research

Session Purpose:

As the vast quantity of microbiome research continues to be translated into therapeutic, nutritional, biomarker and diagnostic
applications, the development of standard operating procedures continues to be crucial to ensure the reproducibility and
regulatory approval of these breakthrough products. The purpose of this theme will be to review the importance of creating
standard protocols to allow for greater comparability and reproducibility between studies without dampening cutting-edge
scientific innovation.


Introduction to the Japan Microbiome Consortium (JMBC): Establishing Standardized Protocols for Microbiome Research

Shingo Arioka
Research Manager
Shionogi & Japan Microbiome Consortium


Lunch & Networking

Sequencing, Bioinformatics & Big Data

Session Purpose:

The advent and accessibility of Next-Generation Sequencing (NGS) tools and bioinformatics analysis has provided the scientific
community a novel way to analyse communities of microorganisms and understand the functional relationship between microbial
dybiosis and disease pathogenesis, without the need of cultivation. More recently, researchers have moved beyond 16S sequencing
to integrate more complex analysis methods including shotgun metagenomics, metabolomics, metatranscriptomics etc. to move
towards species and strain-level profiling. The purpose of this theme will be to review the current NGS methodologies used to
analyse microbiome samples, how complex microbial datasets are being processed, and the technical challenges that need to be
overcome to assist future microbiome studies.


Integrated Omics Approach for Understanding the Gut Ecosystem and Mental Disorders

Hiroshi Ohno MD
Principal Investigator
RIKEN Center for Integrative
Medical Sciences


Metagenomic and Metabolomic Analyses Reveal Dynamic Shifts in Gut Microbiota along the Adenoma-Carcinoma Sequence in Colorectal Cancer

Takuji Yamada
Associate Professor
Tokyo Institute of Technology


Afternoon Coffee & Refreshments Break


Big Data and Multi-Omic Analysis of Microbiome Samples

Ken Kasahara
General Manager of Microbiome Area
Chitose Bio


Genomics and Bioinformatics in Microbiome Research

Jon Sik Chun
Seoul National University


Chairperson Closing Remarks

Shingo Arioka
Research Manager
Shionogi & Japan Microbiome Consortium


Close of Conference Day One & Reception Hosted By Microbiome Movement